Welcome to Adobe GoLive 6
October 1, 2001
For more information, contact:
(856) 256-2422 email@example.com
FOR IMMEDIATE RELEASE
Michael Cunningham Appointed ANNA's Executive Director
The ANNA Board of Directors has appointed Michael Cunningham as ANNA's Executive Director, effective October 1, 2001. Also effective this date, all national office, executive management responsibilities, and communications will be consolidated in the ANNA National Office located in Pitman, NJ.
In his position as Executive Director, Mr. Cunningham will work closely with the Board of Directors, volunteers, members, and the nephrology community in furthering ANNA's mission.
In collaboration with the ANNA Board of Directors, Mr. Cunningham will have responsibility for:
Developing appropriate goals and strategies to advance ANNAs mission.
Establishing operational objectives that support the ANNA Strategic Plan.
Overseeing day-to-day operational management.
Developing financial strategies.
Ensuring that solid planning and budgeting systems are in place.
Working together with key stakeholders within the nephrology community, including organizations and corporations.
Managing ANNA programs and services.
Mr. Cunningham's professional experience includes more than 20 years in health care marketing and association management, including 20 years of corporate marketing within the nephrology market while serving as ANNA's Director of Marketing and Account Executive. His experience also includes working with several association clients within nursing.
Mr. Cunningham works out of the ANNA National Office in Pitman, New Jersey and is Vice President, Marketing for Anthony J. Jannetti, Inc. If you have any questions or wish to contact Mike Cunningham, he can be reached at:
ANNA National Office
East Holly Avenue, Box 56
Pitman, NJ 08071
Toll free 1-888-600-2662
ANNA is a professional nursing association comprised of more than 12,000 nephrology nurses. The association is dedicated to advancing nephrology nursing practice and positively influencing outcomes for patients with kidney or other disease processes requiring replacement therapies through advocacy, scholarship, and excellence.